Celenys Overview

  • Founded
  • 2013
  • Status
  • Out of Business
  • Employees
  • 12
  • Latest Deal Type
  • Liquidation

Celenys General Information


Developer of hyaluronic acid based scaffolds designed for 3D cell culture. The company's hyaluronic acid based scaffolds are based on 3D study model for oncology and stem cell culture.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 75 route de Lyons la forêt
  • 76000 Rouen
  • France
+33 09 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Celenys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 07-Mar-2017 00.000 Completed Bankruptcy: Liquidation
1. Early Stage VC 30-Apr-2014 00.000 00.000 Completed Generating Revenue/Not Profitable
To view Celenys’s complete valuation and funding history, request access »

Celenys Executive Team (3)

Name Title Board Seat Contact Info
Nicolas Dubois Co-Founder & Chief Executive Officer
Elise Demange Ph.D Co-Founder, President, Chief Scientific Officer and Chairman
Agathe Devaux Ph.D Director, Business Development
To view Celenys’s complete executive team members history, request access »

Celenys Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial